Interaction studies of Withania somnifera’s key metabolite Withaferin A with different receptors associated with cardiovascular disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6697|11|3|212-221

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.11, Iss.3, 2015-09, pp. : 212-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Receptors in cardiovascular disease: review and introduction

By Leonardi A.   Sironi G.   Motta G.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 157-161

Elsevier

Access to resources Recommend Favorite

1,4-Dioxane and ergosterol derivatives from Withania somnifera roots

By Misra Laxminarain   Mishra Priyanka   Pandey Archana   Sangwan Rajender S.   Sangwan Neelam S.  

Journal of Asian Natural Products Research, Vol. 14, Iss. 1, 2012-01 ,pp. : 39-45

Taylor & Francis Ltd

Access to resources Recommend Favorite

Unique Medicinal Properties of Withania somnifera: Phytochemical Constituents and Protein Component

By  

Current Pharmaceutical Design, Vol. 22, Iss. 5, 2016-02 ,pp. : 535-540

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Aldosterone and Mineralocorticoid Receptors in Cardiovascular Disease

By Funder John W.  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 3, 2007-01 ,pp. : 151-157

Adis International

Access to resources Recommend Favorite

Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress

By Bhattacharya S.K.   Muruganandam A.V.  

Pharmacology Biochemistry and Behavior, Vol. 75, Iss. 3, 2003-06 ,pp. : 547-555

Elsevier

Access to resources Recommend Favorite